Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

NCT06917664 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

220

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Artery Disease
Ischemic Mitral Regurgitation
Angiotensin Receptor/Neprilysin Inhibitor

Interventions

DRUG: sacubitril/valsartan

Sponsor

China National Center for Cardiovascular Diseases

Collaborators

[object Object]
[object Object]